Navigation Links
Velos to Develop Key System Interface for Clinical Research
Date:3/26/2008

ies who deliver innovative software solutions based on Oracle software. Through access to Oracle's premier products, education, technical services, marketing and sales support, the Oracle PartnerNetwork program provides partners with the resources they need to be successful in today's global economy. Oracle partners are able to offer their customers leading-edge solutions backed by Oracle's position as the world's largest enterprise software company. Partners who are able to demonstrate superior product knowledge, technical expertise and a commitment to doing business with Oracle qualify for the Certified Partner levels. http://oraclepartnernetwork.oracle.com

About Velos

Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to participate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Velos eTools, a companion product to Velos eResearch, empowers customers by giving them ownership and access to functions such as system configuration, data migrations, custom reporting and third party data submissions. Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit http://www.velos.com.

This pr
'/>"/>

SOURCE Velos, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
2. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
3. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
4. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
5. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
6. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
7. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
8. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
9. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
10. ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics
11. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , WHITEHOUSE STATION, N.J., Dec. 1 /PRN...that the U.S. Food and Drug Administration (FDA) h...um bicarbonate 1100 mg capsules), for over-the-cou... will be marketed over-the-counter by Schering-Plo...care division of Merck & Co., Inc. Schering-Pl...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...rch report is available in its catalogue: ,, T...sts to 2015, Competitive Benchmarking, Product Pip...linker.com/p0166817/The-Future-of-Oncology-Therape...marking-Product-Pipeline-and-Deals-Analysis.html ...
(Date:12/1/2009)..., , NEWNAN, Ga., Dec. 1 /PRNewswire/...ialty surface treatments for medical devices and o...nt and Chief Executive Officer, Thomas A. Gordy, w...ade at the Innovations in Cardiovascular Intervent...ve the era of petty self-interest behind and focus...
Breaking Medicine Technology:FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices 2Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 1Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 2Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 3Marking anorexia with a brain protein 49756 1Medical Study Establishes First Ever Long Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement 49755 1
...ta on Newly-Approved Cimzia(R) Presented at Digest...nounced today that data,presented at Digestive Dis...cacy and safety of Cimzia(R) (certolizumab pegol) ... to severe Crohn,s disease. Data also showed,conti...and the remission,rate remained stable in many of ...
... Clinical trial data for Perforomist(TM) (Formoter... at International ATS Conference --, NAPA, Calif....l Conference of the American Thoracic Society (ATS...omist(TM) Inhalation Solution,(formoterol fumarate...tion,and Spiriva(R) (tiotropium; TIO) is significa...
Other Medicine Technology:Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 2Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 3Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 5Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 6Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 7Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 8Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 2Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 3Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 4Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 5Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 6
(Date:12/1/2009)...velopment of simple screening test, expert says ,... a finding that could lead to a simple blood test ...dentified immune system markers that indicate earl...g cancer. , The researchers examined gene expre...ith non-small cell lung cancer and a control group...
(Date:12/1/2009)...would benefit from liver surgery after chemo, stud... News) -- A CT scan of liver tumors caused by the ...ll survival after chemotherapy, researchers report...hemotherapy has been shown to improve survival in ...produce better results in patients having surgery ...
(Date:12/1/2009)...n because pandemic,s course remains unpredictable ...A U.S. health official said Tuesday that H1N1 swin...ly, but many experts agreed the virus could return...idespread in 32 states -- down from 43 states the ...e U.S. Centers for Disease Control and Prevention ...
(Date:12/1/2009)..., 2009)The Clinical Research Building (CRB), at th...as been honored for its sustainability components....tablished by the U.S. Green Building Council and v...ute (GBCI). LEED is the nation,s preeminent progra...een buildings., "Having a LEED certified building...
(Date:12/1/2009)... Ever thought you could quit smoking while you,re ...roundbreaking new system for quitting is easy, pai...enty eight days your cravings and desire to smoke ... (PRWEB) December 1, 2009 -- Izabella had tried...iction to nicotine, smoking at least a pack a day....
Breaking Medicine News(10 mins):Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3
...achytherapy, intensity-modulated radiotherapy (IMR...dy radiotherapy (SBRT) , , PALO ALTO, Calif., Apr...showcase the company,s full spectrum of prostate c...n offers state-of-the-art technology for all five ...
...n goes undetected until rupture , , FRIDAY...at risk of an abdominal aortic aneurysm are gettin...An abdominal aortic aneurysm is a weak area in the...rtic aneurysms initially have no symptoms but can ...
...a erases the advantage, study finds, , , F... in the armed forces tend to be in better health t...xperienced combat duty, that initial health advant...ed Friday at the American Heart Association,s 10th...
...the role of prostaglandins a family of fatty comp...ressure maintenance, researchers at the University... discovered that mice that lack the receptor for o...ole for the type of prostaglandin studied, PG F2-a...
... and Mid-Sized Drug Companies to Adopt "Smart" Dru...O, Calif., April 24 /PRNewswire-FirstCall/ -- ... third party logistics provider Golden State Medic...tions in advance of state and federal mandates. ,...
...s to Medigap Secondary Insurance for Florida,s Mos...a., April 24 The Florida Legislature voted today ...l population of Florida,s kidney failure patients ...d for this legislation. , , Mourning, who is also...
Other Medicine News:Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 2Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 3Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 4Health News:Too Few Screened for Abdominal Aneurysm, Study Says 2Health News:Combat Duty Harms Long-Term Health of Vets 2Health News:Combat Duty Harms Long-Term Health of Vets 3Health News:New target for maintaining healthy blood pressure discovered 2Health News:New target for maintaining healthy blood pressure discovered 3Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 2Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 3Health News:Florida Legislature Renames Proposed Bill to Help State's Kidney Failure Patients "The Alonzo Mourning Access to Care Act" 2
CA-1000 (220V/50Hz)
...que DNA sequencing reagents including linear poly...istry and cyanine-based infrared dyes- coupled wit...ction, ore meaningful raw data, and higher-quality...0 to resolve complex sequences, filling in the gap...
ABL555 Blood gas analyzer
Rapidlink Critical Care Information Management System
Medicine Products: